Registry of Lobbyists
Version 3 of 5 (1997-06-11 to 1997-12-16) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Organization: |
CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
302 - 1111 PRINCE OF WALES DRIVE OTTAWA, ON K2C 3T2 Canada |
| Telephone number: | 613-727-1380 |
| Fax number: | 613-727-1407 |
| Responsible officer name and position during the period of this registration: | JUDY A EROLA, PRESIDENT |
| Description of the organization's activities: | THE PHARMACEUTICAL MANUFACTURERS ASSOCIATION OF CANADA IS THE ASSOCIATION OF CANADA'S RESEARCH-BASED PHARMACEUTICAL INDUSTRY. THE COMPANIES THAT MAKE UP THE MEMBERSHIP OF THE PMAC ARE ENGAGED IN THE RESEARCH AND DEVELOPMENT, PRODUCTION, MARKETING, AND SERVICING OF PRESCRIPTION AND PROFESSIONAL NON-PRESCRIPTION PHARMACEUTICALS. PMAC MEMBERS EMPLOY MORE THAN 17,000 PEOPLE ACROSS CANADA. COMPRISED OF COMPANIES OF ALL SIZES, THE PMAC MEMBERSHIP REFLECTS THE INTERNATIONAL SCOPE OF TODAY'S MODERN PHARMACEUTICAL INDUSTRY AND INCLUDES THE CANADIAN OPERATIONS OF DOMESTIC FIRMS, AS WELL AS THOSE WITH HEADQUARTERS IN OTHER COUNTRIES. THE PMAC MEMBERSHIP IS CURRENTLY MADE UP OF 61 MEMBER COMPANIES. |
| Organization's membership or classes of membership: | FULL MEMBERS - CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO RESEARCH, DEVELOP, MANUFACTURE AND/OR DISTRIBUTE BRAND NAME PHARMACEUTICALS. RESEARCH ASSOCIATE MEMBERS - CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO ARE ENGAGED FOR PROFIT IN RESEARCH AND DEVELOPMENT OF PHARMACEUTICAL PRODUCTS. MANUFACTURING AFFILIATE MEMBERSHIP - CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO ARE ENGAGED IN CUSTOM MANUFACTURING OR CUSTOM PACKAGING, FOR OR SUPPLY PHARMACEUTICAL CHEMICALS TO FULL MEMBERS. |
| Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | ROBERT DUGAL |
| Position title: | DIRECTOR, UNIVERSITY, SCIENTIFIC AND FED. AFFAIRS |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Name: | JUDY EROLA |
| Position title: | PRESIDENT |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Name: | GERRY JEFFCOTT |
| Position title: | DIRECTOR, NATIONAL/PROVINCIAL AFFAIRS AND PHARMACY RELATIONS |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Name: | ARVIND MANI |
| Position title: | RESEARCH ANALYST |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Name: | LEONORA MARKS |
| Position title: | DIRECTOR, POLICY DEVELOPMENT, PROFESSIONAL MEDICAL RELATIONS |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Name: | CHRISTIANE MENARD |
| Position title: | PUBLIC AFFAIRS MANAGER |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Name: | GRANT PERRY |
| Position title: | DIRECTOR, REGULATORY AFFAIRS (FEDERAL), EXECUTIVE |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Name: | KEN VILLAZOR |
| Position title: | MANAGER, PROVINCIAL GOVERNMENT AFFAIRS |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Atlantic Canada Opportunities Agency (ACOA), Environment Canada, Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, MEDICAL RESEARCH COUNCIL, National Research Council (NRC), Natural Sciences and Engineering Research Council (NSERC), Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Revenue Canada (RC), Western Economic Diversification Canada (WD) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Consumer Issues, Environment, Health, Industry, Intellectual Property, Internal Trade, International Relations, International Trade, Regional Development, Science and Technology, Taxation and Finance |
| Subject Matter: Retrospective: | IND. CDA - POLITICAL/BUREAUCRAT. BILL C-91(DRUG PATENT)PMPRB - PATENTED MEDICINES PRICING AND R&D POLICY REVENUE CANADA - BUDGET AND TAXATION ISSUES AFFECTING THE PHARMACEUTICAL INDUSTRYHEALTH CANADA - POLITICAL/BUREAU. COST RECOVERY, DRUG ADVERTISING, REGULATORY POLICIES INT'L TRADE - INTERNATIONAL AID PROGRAMS HEALTH CANADA - KNOWLEDGE IS BEST MEDICINE CAMPAIGN TREASURY BOARD - COST RECOVERY INIATIVES ENVIR. CDA - ISSUES AFFECTING PHARMACEUTICALS REVENUE CDA - ISSUES AFFECTING SCIENTIFIC RESEARCH EXPENDITURES MEDICAL RESEARCH COUNCIL - PMAC/MRC PARTNERSHIP PROGRAM |
| Subject Matter: Prospective: | INDUSTRY CANADA - INTELLECTUAL PROPERTY - BILL C91(DRUG PATENT) AND REVIEW OF THE NOC - PATENT REGULATIONSHEALTH CANADA - COST RECOVERY, DRUG ADVERTISING, KNOWLEDGE CAMPAIGN, INTERNATIONAL MRA'S, DRUG APPROVAL PROCESS, NOC -PATENT REGULATIONS BILL C-91(DRUG PATENT) REVIEW MRC - ONGOING ISSUE WITH PARTNERSHIP INT'L TRADE - ONGOING INTERNATIONAL ISSUES REVENUE CDA - BUDGET ITEMS, SRED ISSUES TREASURY BD - COST RECOVERY, USER FEE POLICY |